Multimodal population brain imaging in the UK Biobank prospective epidemiological study

Karla L. Miller; Fidel Alfaro-Almagro; Neal K. Bangerter; David L. Thomas; Essa Yacoub; Junqian Xu; Andreas J. Bartsch; Saad Jbabdi; Stamatios N. Sotiropoulos; Jesper L R Andersson; Ludovica Griffanti; Gwenaëlle Douaud; Thomas W. Okell; Peter Weale; Iulius Dragonu; Steve Garratt; Sarah Hudson; Rory Collins; Mark Jenkinson; Paul M. Matthews; Stephen M. Smith

doi:10.1038/nn.4393

Multimodal population brain imaging in the UK Biobank prospective epidemiological study

Karla L. Miller, Fidel Alfaro-Almagro, Neal K. Bangerter, David L. Thomas, Essa Yacoub, Junqian Xu, Andreas J. Bartsch, Saad Jbabdi, Stamatios N. Sotiropoulos, Jesper L R Andersson, Ludovica Griffanti, Gwenaëlle Douaud, Thomas W. Okell, Peter Weale, Iulius Dragonu, Steve Garratt, Sarah Hudson, Rory Collins, Mark Jenkinson, Paul M. MatthewsStephen M. Smith

Radiology

Research output: Contribution to journal › Article › peer-review

718 Scopus citations

Abstract

Medical imaging has enormous potential for early disease prediction, but is impeded by the difficulty and expense of acquiring data sets before symptom onset. UK Biobank aims to address this problem directly by acquiring high-quality, consistently acquired imaging data from 100,000 predominantly healthy participants, with health outcomes being tracked over the coming decades. The brain imaging includes structural, diffusion and functional modalities. Along with body and cardiac imaging, genetics, lifestyle measures, biological phenotyping and health records, this imaging is expected to enable discovery of imaging markers of a broad range of diseases at their earliest stages, as well as provide unique insight into disease mechanisms. We describe UK Biobank brain imaging and present results derived from the first 5,000 participants' data release. Although this covers just 5% of the ultimate cohort, it has already yielded a rich range of associations between brain imaging and other measures collected by UK Biobank.

Original language	English (US)
Pages (from-to)	1523-1536
Number of pages	14
Journal	Nature neuroscience
Volume	19
Issue number	11
DOIs	https://doi.org/10.1038/nn.4393
State	Published - Oct 26 2016

Bibliographical note

Funding Information:
Acknowledgments We would like to acknowledge the valuable contributions of members of the UK Biobank Imaging Working Group and the UK Biobank coordinating center. We are very grateful for additional input into the imaging protocol and image processing pipelines from M. Chappell, S. Clare, E. Duff, D. Flitney, M. Hernandez Fernandez, H. Johansen-Berg, P. McCarthy, J. Miller, D. Mortimer, J. Price, G. Salimi-Khorshidi, E. Vallee, D. Vidaurre, M. Webster, A. Winkler, A. Young, E. Auerbach, S. Moeller, K. Ugurbil, D. Alexander, N. Fox, E. Kaden, S. Ourselin, G. Zhang, A. Daducci, T. Stoecker, D. Barch, N. Bloom, G. Burgess, M. Glasser, M. Harms, D. Nolan, B. Fischl, D. Greve, J. Polimeni, T. Nichols, A. Murphy, G. Parker, F. Barkhof, C. Beckmann, M. Mennes, M. Vernooij, N. Weiskopf, C. Rorden and J. Wardlaw. We are grateful for the provision of simultaneous multi-slice (multiband) pulse sequence and reconstruction algorithms from the Center for Magnetic Resonance Research, University of Minnesota. Finally, we are extremely grateful to all UK Biobank study participants, who generously donated their time to make this resource possible. UK Biobank (including the imaging enhancement) has been generously supported by the UK Medical Research Council and the Wellcome Trust. K.L.M. and S.M.S. receive further support from the Wellcome Trust. P.M.M. acknowledges support from the Edmund J Safra Foundation and Lily Safra, the Imperial College Healthcare Trust Biomedical Research Centre, and the Medical Research Council.

Publisher Copyright:
© Nature America, Inc., part of Springer Nature. All rights reserved.

Publisher link

10.1038/nn.4393

http://europepmc.org/articles/pmc5086094

Find It

Find It at U of M Libraries

Cite this

Miller, K. L., Alfaro-Almagro, F., Bangerter, N. K., Thomas, D. L., Yacoub, E., Xu, J., Bartsch, A. J., Jbabdi, S., Sotiropoulos, S. N., Andersson, J. L. R., Griffanti, L., Douaud, G., Okell, T. W., Weale, P., Dragonu, I., Garratt, S., Hudson, S., Collins, R., Jenkinson, M., ... Smith, S. M. (2016). Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nature neuroscience, 19(11), 1523-1536. https://doi.org/10.1038/nn.4393

Miller, KL, Alfaro-Almagro, F, Bangerter, NK, Thomas, DL, Yacoub, E, Xu, J, Bartsch, AJ, Jbabdi, S, Sotiropoulos, SN, Andersson, JLR, Griffanti, L, Douaud, G, Okell, TW, Weale, P, Dragonu, I, Garratt, S, Hudson, S, Collins, R, Jenkinson, M, Matthews, PM & Smith, SM 2016, 'Multimodal population brain imaging in the UK Biobank prospective epidemiological study', Nature neuroscience, vol. 19, no. 11, pp. 1523-1536. https://doi.org/10.1038/nn.4393

@article{dfca4193e99244dfa0a20e2a1d7e0668,

title = "Multimodal population brain imaging in the UK Biobank prospective epidemiological study",

abstract = "Medical imaging has enormous potential for early disease prediction, but is impeded by the difficulty and expense of acquiring data sets before symptom onset. UK Biobank aims to address this problem directly by acquiring high-quality, consistently acquired imaging data from 100,000 predominantly healthy participants, with health outcomes being tracked over the coming decades. The brain imaging includes structural, diffusion and functional modalities. Along with body and cardiac imaging, genetics, lifestyle measures, biological phenotyping and health records, this imaging is expected to enable discovery of imaging markers of a broad range of diseases at their earliest stages, as well as provide unique insight into disease mechanisms. We describe UK Biobank brain imaging and present results derived from the first 5,000 participants' data release. Although this covers just 5% of the ultimate cohort, it has already yielded a rich range of associations between brain imaging and other measures collected by UK Biobank.",

author = "Miller, {Karla L.} and Fidel Alfaro-Almagro and Bangerter, {Neal K.} and Thomas, {David L.} and Essa Yacoub and Junqian Xu and Bartsch, {Andreas J.} and Saad Jbabdi and Sotiropoulos, {Stamatios N.} and Andersson, {Jesper L R} and Ludovica Griffanti and Gwena{\"e}lle Douaud and Okell, {Thomas W.} and Peter Weale and Iulius Dragonu and Steve Garratt and Sarah Hudson and Rory Collins and Mark Jenkinson and Matthews, {Paul M.} and Smith, {Stephen M.}",

note = "Funding Information: Acknowledgments We would like to acknowledge the valuable contributions of members of the UK Biobank Imaging Working Group and the UK Biobank coordinating center. We are very grateful for additional input into the imaging protocol and image processing pipelines from M. Chappell, S. Clare, E. Duff, D. Flitney, M. Hernandez Fernandez, H. Johansen-Berg, P. McCarthy, J. Miller, D. Mortimer, J. Price, G. Salimi-Khorshidi, E. Vallee, D. Vidaurre, M. Webster, A. Winkler, A. Young, E. Auerbach, S. Moeller, K. Ugurbil, D. Alexander, N. Fox, E. Kaden, S. Ourselin, G. Zhang, A. Daducci, T. Stoecker, D. Barch, N. Bloom, G. Burgess, M. Glasser, M. Harms, D. Nolan, B. Fischl, D. Greve, J. Polimeni, T. Nichols, A. Murphy, G. Parker, F. Barkhof, C. Beckmann, M. Mennes, M. Vernooij, N. Weiskopf, C. Rorden and J. Wardlaw. We are grateful for the provision of simultaneous multi-slice (multiband) pulse sequence and reconstruction algorithms from the Center for Magnetic Resonance Research, University of Minnesota. Finally, we are extremely grateful to all UK Biobank study participants, who generously donated their time to make this resource possible. UK Biobank (including the imaging enhancement) has been generously supported by the UK Medical Research Council and the Wellcome Trust. K.L.M. and S.M.S. receive further support from the Wellcome Trust. P.M.M. acknowledges support from the Edmund J Safra Foundation and Lily Safra, the Imperial College Healthcare Trust Biomedical Research Centre, and the Medical Research Council. Publisher Copyright: {\textcopyright} Nature America, Inc., part of Springer Nature. All rights reserved.",

year = "2016",

month = oct,

day = "26",

doi = "10.1038/nn.4393",

language = "English (US)",

volume = "19",

pages = "1523--1536",

journal = "Nature Neuroscience",

issn = "1097-6256",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Multimodal population brain imaging in the UK Biobank prospective epidemiological study

AU - Miller, Karla L.

AU - Alfaro-Almagro, Fidel

AU - Bangerter, Neal K.

AU - Thomas, David L.

AU - Yacoub, Essa

AU - Xu, Junqian

AU - Bartsch, Andreas J.

AU - Jbabdi, Saad

AU - Sotiropoulos, Stamatios N.

AU - Andersson, Jesper L R

AU - Griffanti, Ludovica

AU - Douaud, Gwenaëlle

AU - Okell, Thomas W.

AU - Weale, Peter

AU - Dragonu, Iulius

AU - Garratt, Steve

AU - Hudson, Sarah

AU - Collins, Rory

AU - Jenkinson, Mark

AU - Matthews, Paul M.

AU - Smith, Stephen M.

N1 - Funding Information: Acknowledgments We would like to acknowledge the valuable contributions of members of the UK Biobank Imaging Working Group and the UK Biobank coordinating center. We are very grateful for additional input into the imaging protocol and image processing pipelines from M. Chappell, S. Clare, E. Duff, D. Flitney, M. Hernandez Fernandez, H. Johansen-Berg, P. McCarthy, J. Miller, D. Mortimer, J. Price, G. Salimi-Khorshidi, E. Vallee, D. Vidaurre, M. Webster, A. Winkler, A. Young, E. Auerbach, S. Moeller, K. Ugurbil, D. Alexander, N. Fox, E. Kaden, S. Ourselin, G. Zhang, A. Daducci, T. Stoecker, D. Barch, N. Bloom, G. Burgess, M. Glasser, M. Harms, D. Nolan, B. Fischl, D. Greve, J. Polimeni, T. Nichols, A. Murphy, G. Parker, F. Barkhof, C. Beckmann, M. Mennes, M. Vernooij, N. Weiskopf, C. Rorden and J. Wardlaw. We are grateful for the provision of simultaneous multi-slice (multiband) pulse sequence and reconstruction algorithms from the Center for Magnetic Resonance Research, University of Minnesota. Finally, we are extremely grateful to all UK Biobank study participants, who generously donated their time to make this resource possible. UK Biobank (including the imaging enhancement) has been generously supported by the UK Medical Research Council and the Wellcome Trust. K.L.M. and S.M.S. receive further support from the Wellcome Trust. P.M.M. acknowledges support from the Edmund J Safra Foundation and Lily Safra, the Imperial College Healthcare Trust Biomedical Research Centre, and the Medical Research Council. Publisher Copyright: © Nature America, Inc., part of Springer Nature. All rights reserved.

PY - 2016/10/26

Y1 - 2016/10/26

N2 - Medical imaging has enormous potential for early disease prediction, but is impeded by the difficulty and expense of acquiring data sets before symptom onset. UK Biobank aims to address this problem directly by acquiring high-quality, consistently acquired imaging data from 100,000 predominantly healthy participants, with health outcomes being tracked over the coming decades. The brain imaging includes structural, diffusion and functional modalities. Along with body and cardiac imaging, genetics, lifestyle measures, biological phenotyping and health records, this imaging is expected to enable discovery of imaging markers of a broad range of diseases at their earliest stages, as well as provide unique insight into disease mechanisms. We describe UK Biobank brain imaging and present results derived from the first 5,000 participants' data release. Although this covers just 5% of the ultimate cohort, it has already yielded a rich range of associations between brain imaging and other measures collected by UK Biobank.

AB - Medical imaging has enormous potential for early disease prediction, but is impeded by the difficulty and expense of acquiring data sets before symptom onset. UK Biobank aims to address this problem directly by acquiring high-quality, consistently acquired imaging data from 100,000 predominantly healthy participants, with health outcomes being tracked over the coming decades. The brain imaging includes structural, diffusion and functional modalities. Along with body and cardiac imaging, genetics, lifestyle measures, biological phenotyping and health records, this imaging is expected to enable discovery of imaging markers of a broad range of diseases at their earliest stages, as well as provide unique insight into disease mechanisms. We describe UK Biobank brain imaging and present results derived from the first 5,000 participants' data release. Although this covers just 5% of the ultimate cohort, it has already yielded a rich range of associations between brain imaging and other measures collected by UK Biobank.

UR - http://www.scopus.com/inward/record.url?scp=84988310761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988310761&partnerID=8YFLogxK

U2 - 10.1038/nn.4393

DO - 10.1038/nn.4393

M3 - Article

C2 - 27643430

AN - SCOPUS:84988310761

VL - 19

SP - 1523

EP - 1536

JO - Nature Neuroscience

JF - Nature Neuroscience

SN - 1097-6256

IS - 11

ER -

Multimodal population brain imaging in the UK Biobank prospective epidemiological study

Abstract

Bibliographical note

Publisher link

Find It

Other files and links

Fingerprint

Cite this